• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Accord Healthcare`s Tigecycline Accord Receives Approval in Europe

    EMA

    Xellia Pharms Aps` Generic Tigecycline Receives Approval In US

    FDA

    Aurobindo Pharma`s Generic Tigecycline Receives Approval in US

    FDA

    Apotex`s Generic Tigecycline Receives Approval in US

    FDA

    HomeChoice Partners Receives FDA Form 483

    FDA

    Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection

    EDQM

    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 April 2015

    EMA

    Walgreens Infusion Services, Ongoing Class II recall of Tigecycline various strengths in normal saline because of Lack of sterility assurance.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.